Chronic liver disease
Conditions
Interventions
None listed
Sponsors
Chiba University
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: Subjects must meet all of the following criteria to be included in this study. 1) a) Abnormal alanine aminotransferase (ALT) levels for at least 6 months before screening. Or b) Diagnosed as chronic hepatitis B virus infection, chronic hepatitis C virus infection, fatty liver disease, alcoholic liver injury, primary biliary cholangitis, autoimmune hepatitis, and other chronic liver diseases Or c) Diagnosed with cirrhosis Or d) Diagnosed as primary liver cancer 2) Male or female, at least 20 years of age at time of registration. 3) Subjects must understand all other protocol requirements and voluntarily sign and date an informed consent form prior to the initiation of any screening or study-specific procedures.
Exclusion criteria
Exclusion criteria: 1) Recent history of drug or health, psychological, social problems that could preclude adherence to the protocol. 2) Any condition that could impair safety of subjects or could preclude adherence to the protocol in the opinion of the investigator.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Prognosis | — |
Secondary
| Measure | Time frame |
|---|---|
| Frequency of complication | — |
Countries
Japan
Contacts
Public ContactMasanori Inoue
Chiba University, Graduate school of medicine Department of Gastroenterology
Outcome results
None listed